Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure;Przetrwałe migotanie przedsionków z objawami niewydolności serca: Skuteczna kardiowersja poprawia wydolnogś ć wysiłkowa̧

Kardiologia Polska

Volumn 59, Issue 9, 2003, Pages 213-223

  Wozakowska Kapłon, Beata ^a,b   Opolski, Grzegorz ^c   Piotrowicz, Ryszard ^d  

^a Regional District Hospital   (Poland)

^b Swietokrzyskie Centrum Kardiologii Poland   (Poland)

^c Kat Klin Chorob Wewnetrz Kardiol   (Poland)

^d INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Atrial fibrillation; Cardioversion; Exercise testing

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MALE; OXYGEN CONSUMPTION; RECURRENT DISEASE; SINUS RHYTHM;

EID: 0141733166     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kannel W.B., Abbott R.D., Savage D.D.: Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N. Engl. J. Med. 1982, 306, 1018-1022.
2. Naito M., David D., Michelson E.L. et al.: The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am. Heart J. 1983, 106, 284-91.
3. Clark D.M., Plumb V.J., Epstein A.E. et al.: Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J. Am. Coll. Cardiol. 1997, 30, 1039-45.
4. Lip G.Y.H.: Atrial Fibrillation in clinical practice. Martin Dunitz Ltd, London, 2001.
5. Packer D.L., Bardy G.H., Worley S.J. et al.: Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am. J. Cardiol. 1986, 57, 563-570.
6. Psaty B.M., Manolio T.A., Kuller L.H. et al.: Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997, 96, 2455-61.
7. Dries D.L., Exner D.V., Gersh B.J. et al.: Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials: Studies of Left Ventricular Dysfunction. J. Am. Coll. Cardiol. 1998, 32, 695-703.
8. Van Gelder I.C., Crijns H.J., Blanksma P.K. et al.: Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am. J. Cardiol. 1993, 72, 560-6.
9. Gosselink A.T.M., Crijns H.J.G.M., Van Den Berg M.P. et al.: Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. Br. Heart J. 1994, 72, 161-6.
10. Upshaw C.B. Jr.: Hemodynamic changes after cardioversion of chronic atrial fibrillation. Arch. Intern. Med. 1997, 157, 1070-6.
11. Van den Berg M.P., Tuinenburg A.E., Van Veldhuisen D.J. et al.: Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure. Int. J. Cardiol. 1998, 63, 63-70.
12. Kennedy H.L., Podrid P.J.: Role of Holter monitoring and exercise testing for arrhythmia assessment and management. In: Podrid P.J. and Kowey P.R. red. Cardiac Arrhythmia. Mechanisms, Diagnosis & Management - 2nd ed. Lippincott Williams & Wilkins. Philadelphia 2001, 165-193.
13. Kastor J.A.: Arrhythmias 2nd ed. WB Saunders Company. Philadelphia 2000, 39-130.
14. Khaja F., Parker J.O.: Hemodynamic effects of cardioversion in chronic atrial fibrillation. Arch. Intern. Med. 1972, 129, 433-40.
15. Atwood J.E., Myers J., Sullivan M. et al.: The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation. Am. Heart J. 1989, 118, 913-18.
16. Lipkin D.P., Frenneaux M., Stewart R. et al.: Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br. Heart J. 1988, 59, 572-7.
17. Hohnloser S.F., Kuck K.H., Lilienthal J.: Rhythm or rate control in atrial fibrillation - Pharmacological intervention in atrial fibrillation (PIAF): a randomised trial. Lancet 2000, 356, 1789-1794.
18. Opolski G., Torbicki A., Kosior D. et al.: Rate control versus rhythm control in patients with nonvalvular chronic atrial fibrillation: the results of HOT CAFE Polish study. 24th Congress of the European Society of Cardiology. Berlin 2002.
19. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators, A comparison of rate control and rhythm control in patients with atrial fibrillation. New Engl. J. Med. 2002, 347, 1825-1833.